As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease and ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

The biochemist introduced the first heel-prick tests for newborn babies in Spain, protecting infants from life-changing ...

GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is still studying the idea. A potential challenge: Insurers would have to embrace ...